🇺🇸

US SEC Filing Intelligence

· daily

Mega Contracts Monitor ($100M+) — May 21, 2026

This single-contract digest covers a $432.5 million civilian award from the National Institutes of Health (NIH) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., representing the entirety of the period's activity. The contract is a cost-plus-fixed-fee delivery order to operate a government-owned, contractor-operated (GOCO) R&D facility, signaling stable but margin-constrained revenue for Leidos. With zero defense-related awards, the digest highlights a pure civilian R&D services theme, contrasting with typical defense-heavy contract flows. The highest-conviction signal is the low pricing risk and multi-year duration through May 2026, though only $1.15 million has been outlayed to date, creating execution pace uncertainty. A key risk is the early-stage outlay rate, which must accelerate to realize the full $432.5 million value.

1 total filings
· daily

High-Value Federal Grants ($5M+) — May 21, 2026

This digest covers $755.9 million in high-value federal grants and contracts, all from civilian agencies (0% defense), with the Department of Health and Human Services (HHS) as the dominant buyer accounting for $685.3 million (90.7%) of the total. The highest-conviction signal is Leidos Biomedical Research's $432.5 million NIH GOCO facility contract, offering a stable, multi-year cost-plus revenue stream, though early-stage outlay (only $1.15M funded) warrants monitoring. A key risk is the upcoming expiration of SOFTRAMS LLC's $80.7 million CMS IT contract in August 2024, creating a potential revenue cliff for the small business. The digest reveals a civilian IT and life sciences R&D theme, with no defense exposure, and a mix of cost-plus and fixed-price structures that balance margin stability against execution risk.

5 total filings
· daily

General Federal Contracts — May 21, 2026

This digest covers $755.9 million in total obligations across 5 civilian contracts (0 defense-related), with the Department of Health and Human Services (HHS) as the dominant agency, accounting for $684.6 million (90.6%) of the total. The highest-conviction signal is Leidos Biomedical Research's $432.5 million NIH GOCO facility contract, providing a stable, multi-year revenue stream with low pricing risk. However, the digest reveals a key risk: two contracts (SOFTRAMS LLC and Chimerix) face near-term expiration or have minimal outlays, creating potential revenue cliffs or execution uncertainty. The absence of defense contracts underscores a civilian-heavy procurement environment, with HHS life sciences and IT modernization as the dominant sector themes. Investors should watch Peraton's CMS fraud prevention contract for expansion options and GDIT's EMITS 2 for option exercises as key catalysts.

5 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 21, 2026

The 25 filings reveal a bifurcated landscape. The dominant theme is the landmark $52B merger-of-equals between **AvalonBay (AVB)** and **Equity Residential (EQR)**, generating $125M in net synergies and creating the largest multifamily REIT. However, the sheer volume of 8 related filings signals both heightened management attention and potential shareholder skepticism, warranting close monitoring. Separately, **Applied Materials (AMAT)** posted exceptional results with net income up 45.5% YoY and EPS of $6.05, demonstrating robust semi-equipment demand, though operating cash flow growth lagged. At the other extreme, **Apple iSports Group** remains cash-negative with zero revenue and a widening deficit, a clear distress case. **Zoom Communications** showed a mixed picture: revenue grew 5.5% YoY and AI-user uptake surged 184%, but churn ticked up to 3.0%. Capital allocation patterns are split—Radian issued $8M in sign-on equity for a new CEO, while PSBD extended buybacks, and AMAT slowed repurchases sharply to $737M from $3.0B. Overall, the Technology sector shows pockets of strong operational momentum (AMAT, Zoom) alongside significant restructuring and capital reallocation events, creating actionable divergence.

16 high priority 9 medium 25 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 21, 2026

The 28 filings for the NASDAQ-100 intelligence stream are dominated by the landmark AvalonBay-Equity Residential merger of equals, a $69B transaction that reshapes the multifamily REIT landscape and signals a sector-wide push for scale amid a maturing market. Outside this mega-deal, the data reveals a stark divergence in corporate health: Applied Materials posted exceptional 45.5% net income growth, while Apple iSports Group faces a liquidity crisis with zero revenue and a near-zero cash balance. Capital allocation trends are mixed, with Alphabet tapping the yen bond market for $5.3B and Sun Communities divesting UK assets for $1.03B to refocus on North America. Insider activity is notably absent across most filings, but several companies show strong shareholder support for governance proposals. The period-over-period data highlights a clear 'barbell' market, where cash-rich tech giants and distressed micro-caps coexist, demanding a selective investment approach.

18 high priority 10 medium 28 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 21, 2026

The 50 filings for the S&P 500 Financials sector on May 21, 2026, reveal a sector bifurcated between those executing strategic transformations and those facing acute liquidity stress. The most dominant theme is a wave of corporate restructuring, headlined by the $69 billion AvalonBay-Equity Residential merger of equals—the largest multifamily REIT combination ever—which signals a drive for scale and $175M in projected synergies. On capital allocation, we see contrasting patterns: Deere & Co. maintained a steady $4.5-5.0B guidance despite a 39% profit collapse in Production & Ag, while Shoe Carnival swung to a GAAP loss from $13.6M in transition charges. Period-over-period data shows 5 of the 8 operating companies with revenue or net income comparisons experienced declines or flat results, with Barnwell Industries posting a 29% revenue drop and a 184% cash burn increase. A cluster of 14 Puerto Rico closed-end funds announced strategic reviews to merge into open-end structures, indicating a sector-wide push for liquidity solutions. Insider and governance activity was notable: Rocket Pharmaceuticals saw 31.8% of votes withheld from a director, and Medallion Financial is in a proxy fight while boasting record earnings. Cash positions are eroding at smaller firms—Dalrada Financial saw cash plunge 52% to $82.6K—while larger entities like Cognizant accessed a $1B revolver. The overall picture is one of defensive positioning and portfolio optimization, with management teams acting decisively to address structural challenges.

27 high priority 23 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 21, 2026

The 50 filings from the S&P 500 Consumer Staples sector reveal a sector bifurcating between scale-driven leaders and challenged players. Walmart's strong Q1 FY27 (revenue +7.3% YoY, eCommerce +26%) contrasts with a sharp negative free cash flow swing (-$2.4B YoY), signaling aggressive investment. A major portfolio restructuring is underway as Kontoor Brands sells its Lee® business for up to $1B to focus on higher-growth brands, a move that will likely reshape the apparel landscape. Capital allocation is a key theme, with Kraft Heinz aggressively managing its balance sheet via a $1.1B debt tender, while Constellation Brands bolsters its board with top marketing talent from McDonald's. Insider activity is limited in this batch, but the Gabelli Dividend & Income Trust's proxy fight with Saba Capital Management highlights a broader activist push in closed-end funds, with performance data showing GDV up 29% in the last twelve months. Overall, the sector shows strong top-line growth for dominant players, but margin pressures from fuel costs and investment cycles are evident, creating a 'winners-take-most' dynamic.

19 high priority 31 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 21, 2026

The 50 filings from S&P 500 Industrials reveal a sector bifurcated between resilient capital-goods players and deeply distressed small-caps. Deere & Co. posted a 5% revenue increase but saw its Production & Precision Agriculture segment profit plunge 39%, while Advanced Drainage Systems reported 9.9% top-line growth but a 54% GAAP net income collapse due to acquisition costs. The most transformative event is the $69B AvalonBay/Equity Residential merger of equals, creating a multifamily REIT behemoth with $125M in net synergies. Capital allocation is defensive: Tractor Supply secured a new credit facility, Barnwell raised $3.4M via equity issuance, and Unity Bancorp maintained a $0.16 dividend. A wave of 14 Puerto Rico closed-end funds announced strategic reviews to convert to open-end structures, signaling a structural shift in that market. Insider activity is sparse but notable, with Nocopi Technologies insiders participating in a private placement alongside a transformative acquisition. The overarching theme is 'scale or die'—companies are using M&A and restructuring to navigate margin pressure while cash-strapped micro-caps like Dalrada face acute liquidity risk.

26 high priority 24 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 21, 2026

The S&P 500 Energy sector filings today reveal a bifurcated landscape: aggressive capital deployment into upstream acreage and midstream consolidation, contrasted with mixed operational performance and margin pressure. Devon Energy's $2.6B Delaware Basin acquisition at $161,500/acre signals strong conviction in Permian economics, while Baker Hughes' EC filing for the Chart Industries merger (expected July 2026) advances a transformative midstream deal. However, Copart's Q3 FY2026 results show domestic revenue stagnation (U.S. service revenues -2.1% YoY for nine months) offset by international strength (+11.4% YoY), and ONEOK's annual meeting confirmed stable governance. EOG Resources' doubling of its buyback authorization to $20B (with $2.9B remaining) underscores sector-wide capital return momentum, though Nocopi's dilutive $2.65M acquisition (500K shares issued) highlights small-cap execution risk. Insider activity is muted across filings, but the absence of selling in large caps is notable. Portfolio-level trends show capital discipline (buybacks > dividends) and a pivot toward high-return basin acreage, while margin compression in services (Copart U.S. operating income -0.5% YoY) warrants monitoring.

2 high priority 7 medium 9 total filings
· daily

US Material Events SEC 8-K Filings — May 21, 2026

The May 21, 2026, material events stream is dominated by transformative M&A and capital allocation activity, signaling a period of aggressive portfolio reshaping and strategic pivots across sectors. The $69 billion AvalonBay/Equity Residential merger of equals is the headline event, creating a multifamily REIT behemoth with $175 million in targeted synergies, though leadership transition risks and shareholder approval hurdles remain. Concurrently, we see a wave of capital market activity: Onto Innovation's $1.3B zero-coupon convertible offering (with a 50% conversion premium) and Trinity Capital's $300M note issuance highlight a bifurcated market where high-growth and credit-oriented firms are aggressively locking in low-cost, long-duration capital. A notable pattern of strategic divestitures and pivots is emerging, with Sun Communities selling its UK assets for $1.03B to refocus on North America, Skillsoft divesting Global Knowledge to sharpen its AI focus, and Hoth Therapeutics restructuring entirely into an AI semiconductor company. Insider and governance signals are mixed; while several companies are strengthening boards with high-profile talent (Constellation Brands, Veritone), others face significant shareholder dissent on compensation and equity plans (BankUnited, Rithm Capital), and a wave of CFO retirements and transitions (Erie Indemnity, Omega Healthcare, Skillsoft) introduces execution risk. The data reveals a market that is rewarding strategic clarity and financial engineering, while punishing governance lapses and unclear strategies.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 21, 2026

The 50 filings for Dow 30 constituents on May 21, 2026, are dominated by a single mega-deal: the $52B all-stock merger of equals between AvalonBay Communities and Equity Residential, creating the largest multifamily REIT in history with over 180,000 units. This transaction, covered across six separate filings, signals a defensive consolidation play in a maturing sector where geographic performance has diverged sharply. Beyond AvalonBay, the batch reveals a defensive tilt in capital allocation: S&P Global advances its Mobility spin-off (record date June 15, distribution July 1), Baker Hughes pushes its Chart Industries acquisition through EC review for a July close, and Advance Auto Parts reports its strongest comparable sales in five years (up 3.5%) alongside massive margin recovery (adjusted operating income up 410 bps YoY). However, red flags are flashing for smaller-cap names: Apple iSports Group has just $860 cash remaining with zero revenue, SpringBig Holdings lost board control to noteholders, and Hemab Therapeutics' cash burn is accelerating. Period-over-period data shows wide divergence—Walmart's e-commerce surged 26% globally while Barnwell Industries' revenue fell 29%, illustrating the bifurcation between scale-driven leaders and energy-exposed laggards.

25 high priority 25 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — May 21, 2026

Today's digest is dominated by two transformative mega-mergers in the real estate sector: AvalonBay Communities and Equity Residential's $69 billion all-stock merger of equals, and Sun Communities' $1.03 billion sale of its UK assets to refocus on North America. These deals signal a wave of consolidation and strategic refocusing in the REIT space. On the earnings front, Deere & Co. reported a mixed quarter with a 2% net income decline but maintained full-year guidance, while e.l.f. Beauty saw a sharp 76.5% net income drop despite 24.6% revenue growth due to acquisition-related charges. The biotech sector showed a stark contrast, with Immix Biopharma reporting a compelling 95% CR rate in a Phase 2 trial, while Brainstorm Cell Therapeutics filed for a dilutive offering with flat losses. A notable pattern is the surge in Puerto Rico closed-end funds (14 filings) announcing strategic reviews to convert to open-end structures, a significant liquidity event for a niche market. Overall, the day is characterized by high-conviction corporate actions, mixed earnings quality, and a cautious capital-raising environment for smaller companies.

27 high priority 23 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 21, 2026

The 50 filings for the S&P 500 Consumer Discretionary sector reveal a bifurcated landscape where discount retailers and value-oriented concepts are thriving, while other segments face margin pressure and liquidity concerns. Walmart and Ross Stores delivered standout quarters with strong revenue growth of 7.3% and 21% YoY respectively, driven by market share gains and value-seeking consumers, though Walmart's free cash flow turned sharply negative. e.l.f. Beauty reported robust 24.6% net sales growth but saw net income collapse 76.5% due to acquisition-related charges, highlighting the cost of aggressive M&A. The homebuilding sector saw a major unsolicited bid from Dream Finders Homes for Beazer Homes, signaling potential consolidation. Auto and restaurant filings were sparse, but Ford's DOE loan agreement for battery facilities indicates continued EV investment. A significant cluster of 14 Puerto Rico closed-end funds announced strategic reviews to convert to open-end structures, a major liquidity event for that market. Insider trading activity was minimal across filings, but several annual meetings revealed notable shareholder dissent on executive compensation, particularly at First Watch and Braemar Hotels.

25 high priority 25 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 21, 2026

The 32 filings in this S&P 500 Healthcare stream reveal a sector in transition, with strong operational performance at firms like Cirrus Logic (revenue +5.3% YoY, net income +25%) contrasting with acute distress at Dalrada Technology (revenue -44% YoY, negative equity). Capital allocation is active: News Corp authorized a $1B buyback, Broadridge raised its dividend, and Medallion Financial highlighted record earnings amid a proxy fight. M&A activity is notable with Columbia Financial/Northfield Bancorp merger and Greenland Mines' $35M acquisition. Insider trading is sparse, but the proxy contest at Medallion and withheld votes at Kingsway and HBT Financial signal governance concerns. Forward-looking catalysts include Jupiter Neurosciences' $2M offering for Parkinson's trial and NanoViricides' Ebola commentary. Overall, the sector shows bifurcation between profitable incumbents and cash-burning biotechs, with regulatory and shareholder activism risks.

8 high priority 24 medium 32 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 21, 2026

This batch of 8 proxy filings reveals a bifurcated landscape: 25% of filers are in severe financial distress, resorting to reverse stock splits and SPAC deadline extensions to preserve listing and survival, while the remaining companies present stable governance with routine proposals. A critical theme is the high rate of leadership instability, most notably at Cue Biopharma which has cycled through three CEOs in under eight months amidst a transformative licensing deal, signaling deep operational turmoil. Capital allocation actions are defensive rather than growth-oriented, with Allied Gaming, Edible Garden, and Centurion Acquisition all seeking shareholder approval for capital structure changes that dilute or restructure equity. Insider activity across the set is minimal and not signaling conviction—most insider holdings are under 1%, and no material insider buying or selling was detected in any filing. Forward-looking data is sparse, limited to corporate action deadlines rather than operational guidance, creating a vacuum of performance visibility that heightens risk for smaller-cap filers. The SPAC sector remains under acute time pressure, with Centurion's $312 million trust at risk of full liquidation if its extension fails, representing the largest binary event in this cohort.

8 high priority 8 total filings
· daily

US IPO Pipeline SEC S-1 Filings — May 21, 2026

The IPO pipeline on May 21, 2026, reveals a bifurcated market: two distressed biotech resale registrations (Brainstorm Cell Therapeutics and Azitra) signal severe capital needs and shareholder dilution, while one blank-check company (BTECH Corp) launches a $200 million SPAC targeting the oil and gas and energy transition sectors. Period-over-period data shows Brainstorm's net losses flat at $22.589 million for two consecutive years, indicating no operational progress, while Azitra's assets of only $5.0 million and a going concern opinion underscore acute financial fragility. In contrast, BTECH's SPAC structure offers a clean slate with no operating history, but immediate dilution from sponsor shares at $0.003 per share is a structural risk. The absence of insider trading activity across all three filings suggests management is not signaling conviction through personal investment. The overarching theme is capital desperation in biotech versus speculative SPAC capital formation in energy, with all three filings carrying high dilution risk for investors.

3 high priority 3 total filings
· daily

Global High-Priority Regulatory Events — May 21, 2026

Today's filing stream (May 21, 2026) reveals a market dominated by three major themes: a landmark consolidation in US REITs with the $69B AvalonBay-Equity Residential merger, a systemic liquidity crisis at Dalrada Technology Group, and a coordinated structural shift by 14 Puerto Rico closed-end funds toward open-end structures. Period-over-period data shows decelerating growth in Indian conglomerates (ITC's revenue +10% YoY but profit only +1%) and extreme revenue contraction in micro-cap energy (Barnwell -29% YoY) and technology (Dalrada -44% YoY). Capital allocation is mixed—aggressive buybacks from Dhanuka Agritech (₹70Cr) and Zydus Lifesciences (₹1,100Cr) contrast with severe cash burn at Dalrada (cash down 52% to $82.6K). A notable pattern of leadership churn emerged with Glimpse Group losing its entire C-suite and Radian Group announcing a CEO transition, while insider activity remains sparse across the stream. The most actionable signals arise from the AvalonBay-EQR merger synergies ($175M gross), Obsidian Therapeutics' promising Phase 2 melanoma data (67% ORR), and the pivot-to-liquidity event across 14 Puerto Rico funds, which may unlock trapped NAV for investors.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — May 21, 2026

The 22 filings reveal a bifurcated market: consumer-facing and tech companies (e.g., e.l.f. Beauty, Logitech, Ralph Lauren) show robust top-line growth, but margin pressures from rising costs and acquisition-related charges are compressing net income. Conversely, the semiconductor and industrial sectors (Applied Materials, Allegro MicroSystems, Nordson) demonstrate strong cyclical recoveries with double-digit revenue and earnings growth. A critical undercurrent is acute liquidity stress at micro-cap companies (Dalrada, Apple iSports, Barnwell), where cash burn and negative equity signal potential distress. Capital allocation is a key differentiator: strong operators like Cirrus Logic and Hamilton Lane are returning capital via buybacks, while others (Advanced Drainage Systems, Thermon) are absorbing restructuring costs. Insider trading data is sparse, but the lack of insider buying at struggling firms is a notable negative signal. The overarching theme is that quality and scale are rewarded, while smaller, cash-poor entities face existential risks.

22 high priority 22 total filings
· daily

US SEC Trading Suspension Halt Orders — May 21, 2026

The two filings in this stream both involve US exchange listing compliance issues, highlighting a theme of regulatory and financial distress among smaller-cap companies. Picard Medical shows a stark contrast between strong operational improvement (85% YoY revenue growth, achieving a positive gross margin of 24%) and a deteriorating balance sheet (stockholders' deficit of $(1.4)M), leading to two NYSE American delisting notices. Hub Group's situation is a non-operational, administrative delay in filing its Q1 2026 10-Q, following a prior delay on its 2025 10-K, which has resulted in a Nasdaq non-compliance notice. The key portfolio-level trend is the divergence between operational performance and financial/regulatory health, with Picard's growth being overshadowed by solvency risks, while Hub Group's risk is purely procedural. The most critical development is Picard's June 7, 2026 deadline to submit a compliance plan, which will be a key catalyst for its stock. No insider trading activity was reported in either filing, removing a key sentiment gauge.

2 high priority 2 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 21, 2026

The 50 filings reveal a bifurcated market with aggressive capital raising and strategic portfolio reshaping amid rising distress signals. A dominant theme is the wave of equity and debt offerings, with 12 companies raising capital through dilutive stock sales, convertible notes, or private placements, signaling acute cash needs. Concurrently, major portfolio optimization is underway, highlighted by the $69 billion AvalonBay/Equity Residential merger of equals and significant divestitures by Kontoor Brands (Lee® for up to $1B), Conduent (Public Transit for $164M), and Sun Communities (UK assets for ~$1.03B). Distress is concentrated among micro-cap biotechs and struggling tech firms, with 4 companies executing reverse stock splits to maintain exchange listings and 2 receiving delisting notices. Period-over-period data, though limited, shows mixed results: Hims & Hers grew revenue 44.8% YoY but missed guidance, while Picard Medical grew revenue 85% YoY but saw net losses widen. Insider activity is sparse, but the prevalence of related-party transactions and distressed financings suggests management is prioritizing survival over shareholder value. The overall sentiment is cautious, with a clear trend toward deleveraging, portfolio simplification, and reliance on capital markets for liquidity.

50 high priority 50 total filings